SR
Scott M Rocklage
10% Owner

Scott M Rocklage insider trades: Skye Bioscience (SKYE) stock buys and sales

10% Owner, Skye Bioscience Last trade Sep 23, 2026 79 Form 4 filings
$3.4M
Sold, last 12 months
10 sales
$0
Bought, last 12 months
0 buys
88
Open-market trades
since 2013
21
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Scott reports to the SEC

and 15 more companies

Open-market buys and sales

88 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 23, 2026SKYE↓ Sell$230K
Sep 23, 2026SKYE↓ Sell$9K
Sep 16, 2026SKYE↓ Sell$62K
Sep 16, 2026SKYE↓ Sell$2K
Aug 20, 2026SKYE↓ Sell$118K
Aug 20, 2026SKYE↓ Sell$21K
Aug 20, 2026SKYE↓ Sell$853
Aug 7, 2026TRDA↓ Sell$432K
Jul 31, 2026TRDA↓ Sell$807K
Nov 14, 2025TRDA↓ Sell$1.8M
Aug 22, 2025SKYE↓ Sell$770K
Aug 22, 2025SKYE↓ Sell$30K
Jul 9, 2025TRDA↓ Sell$151K
Jul 9, 2025TRDA↓ Sell$52K
Jul 1, 2025TRDA↓ Sell$644K
Jul 1, 2025TRDA↓ Sell$223K
Sep 13, 2024SKYE↓ Sell$1.5M
Sep 13, 2024SKYE↓ Sell$253K
Sep 13, 2024SKYE↓ Sell$10K
Mar 13, 2024SKYE↑ Buy$4.5M
Jan 31, 2024SKYE↑ Buy$12.0M
Apr 10, 2023PEAR↓ Sell$1.5M
Apr 10, 2023PEAR↓ Sell$381K
Apr 10, 2023PEAR↓ Sell$64K
Mar 7, 2023RLYB↓ Sell$820K
Nov 15, 2022PEAR↓ Sell$277K
Nov 15, 2022PEAR↓ Sell$12K
Nov 2, 2022PEAR↓ Sell$144K
Nov 2, 2022PEAR↓ Sell$6K
Oct 10, 2022SCPH↓ Sell$2.0M
Oct 10, 2022SCPH↓ Sell$385K
Oct 10, 2022SCPH↓ Sell$84K
Sep 16, 2022PEAR↓ Sell$1.0M
Sep 16, 2022PEAR↓ Sell$42K
Sep 8, 2022PEAR↓ Sell$1.5M
Sep 8, 2022PEAR↓ Sell$63K
Sep 7, 2022SCPH↓ Sell$894K
Sep 7, 2022SCPH↓ Sell$165K
Sep 7, 2022SCPH↓ Sell$37K
Aug 18, 2022PEAR↓ Sell$634K
Aug 18, 2022PEAR↓ Sell$26K
Jun 3, 2022RLYB↓ Sell$1.2M
Jun 3, 2022RLYB↓ Sell$629K
May 23, 2022RLYB↓ Sell$864K
May 23, 2022RLYB↓ Sell$436K
Apr 11, 2022SCPH↓ Sell$1.1M
Apr 11, 2022SCPH↓ Sell$204K
Apr 11, 2022SCPH↓ Sell$46K
Feb 8, 2022RLYB↓ Sell$2.7M
Nov 2, 2021TRDA↑ Buy$5.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SKYE insiders

Open-market trades in the last 12 months

About Scott M Rocklage's insider trades

Scott M Rocklage is a 10% owner of Skye Bioscience (SKYE). Since Nov 20, 2013, Scott has reported 19 open-market purchases worth $78.7M and 69 sales worth $166.6M on SEC Form 4. In the last 12 months: 10 sales ($3.4M).

Their filings also include conversions (13 filings), grants and awards (10 filings), other transactions (6 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SKYE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.